CINECA IRIS Institutional Research Information System

PASQUALI, LIVIA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 8.577
EU - Europa 4.004
AS - Asia 3.591
SA - Sud America 580
AF - Africa 204
OC - Oceania 31
Continente sconosciuto - Info sul continente non disponibili 1
Totale 16.988
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 8.298
IT - Italia 1.712
CN - Cina 1.381
SG - Singapore 881
HK - Hong Kong 567
BR - Brasile 509
SE - Svezia 486
DE - Germania 464
BG - Bulgaria 319
CA - Canada 242
TR - Turchia 229
GB - Regno Unito 218
UA - Ucraina 159
FI - Finlandia 152
VN - Vietnam 145
RU - Federazione Russa 142
IN - India 134
AT - Austria 105
CI - Costa d'Avorio 86
CH - Svizzera 67
FR - Francia 61
SN - Senegal 42
JP - Giappone 37
BD - Bangladesh 31
KR - Corea 30
AR - Argentina 27
PL - Polonia 22
IQ - Iraq 21
NG - Nigeria 21
MX - Messico 19
AU - Australia 18
ES - Italia 17
BE - Belgio 16
NL - Olanda 14
TW - Taiwan 14
NZ - Nuova Zelanda 13
SA - Arabia Saudita 13
EG - Egitto 12
IR - Iran 11
PK - Pakistan 11
UZ - Uzbekistan 11
EC - Ecuador 10
VE - Venezuela 10
ZA - Sudafrica 10
IE - Irlanda 9
MA - Marocco 9
MY - Malesia 9
BJ - Benin 8
CZ - Repubblica Ceca 8
ID - Indonesia 7
LT - Lituania 7
AZ - Azerbaigian 6
UY - Uruguay 6
AE - Emirati Arabi Uniti 5
HU - Ungheria 5
JO - Giordania 5
LB - Libano 5
PE - Perù 5
CO - Colombia 4
DK - Danimarca 4
IL - Israele 4
KZ - Kazakistan 4
PA - Panama 4
PS - Palestinian Territory 4
PY - Paraguay 4
TN - Tunisia 4
DO - Repubblica Dominicana 3
GR - Grecia 3
KE - Kenya 3
KG - Kirghizistan 3
KW - Kuwait 3
LY - Libia 3
ME - Montenegro 3
OM - Oman 3
PT - Portogallo 3
QA - Qatar 3
TH - Thailandia 3
BA - Bosnia-Erzegovina 2
BO - Bolivia 2
DZ - Algeria 2
ET - Etiopia 2
GT - Guatemala 2
HN - Honduras 2
HR - Croazia 2
JM - Giamaica 2
NP - Nepal 2
PH - Filippine 2
AF - Afghanistan, Repubblica islamica di 1
AL - Albania 1
AM - Armenia 1
AO - Angola 1
BB - Barbados 1
BH - Bahrain 1
BN - Brunei Darussalam 1
CL - Cile 1
CR - Costa Rica 1
EE - Estonia 1
EU - Europa 1
GA - Gabon 1
GY - Guiana 1
Totale 16.979
Salva come PNG Salva come JPEG
Città #
Woodbridge 1.096
Ann Arbor 842
Ashburn 685
Santa Clara 648
Shanghai 628
Houston 621
Chandler 591
Hong Kong 554
Fairfield 524
Serra 458
Singapore 392
Milan 316
Sofia 316
Wilmington 256
Beijing 233
Seattle 222
New York 211
Ottawa 205
Jacksonville 201
Cambridge 195
Izmir 166
Boardman 163
Princeton 143
Florence 129
Lawrence 128
Medford 118
Nanjing 112
Livorno 95
Vienna 94
Los Angeles 87
Abidjan 86
Des Moines 70
Dong Ket 66
Munich 62
Pisa 61
Rome 61
Nanchang 58
Dallas 55
Bern 54
Istanbul 49
London 49
Columbus 47
Dearborn 47
The Dalles 46
Dakar 42
Bremen 41
Ogden 41
Jüchen 40
Fondi 39
Redwood City 38
Frankfurt am Main 37
São Paulo 35
Hefei 30
San Diego 30
Falls Church 29
Pune 29
Council Bluffs 28
Düsseldorf 28
Tokyo 28
Boulder 27
Rio de Janeiro 25
Shenyang 24
Hebei 23
Seoul 23
Kunming 22
Lagos 21
Lancaster 21
Changsha 20
Hangzhou 20
Warsaw 20
Turku 19
Norwalk 18
Helsinki 15
Tianjin 15
Belo Horizonte 14
Brussels 14
Detroit 14
Jiaxing 13
Nürnberg 13
Toronto 13
Washington 13
Fuzhou 12
Hyderabad 12
Trieste 12
Brasília 11
Dhaka 10
Orange 10
Phoenix 10
Porto Alegre 10
San Francisco 10
Buenos Aires 9
Guangzhou 9
Tashkent 9
Uruguaiana 9
Zurich 9
Auburn Hills 8
Baghdad 8
Christchurch 8
Cotonou 8
Delhi 8
Totale 12.344
Salva come PNG Salva come JPEG
Nome #
Reliability, practice effects, and change indices for Rao's Brief Repeatable Battery 346
MPTP Neurotoxicity: Actions, Mechanisms, and Animal Modelling of Parkinson’s Disease 320
The role of mitochondria in stem cell biology 206
Lack of association between the APEX1 Asp148Glu polymorphism and sporadic amyotrophic lateral sclerosis 201
Clinical Trials for Neuroprotection in ALS 192
The effect of air pollution on COVID-19 severity in a sample of patients with multiple sclerosis 188
A clinical and laboratory study evaluating the profile of cytokine levels in relapsing remitting and secondary progressive multiple sclerosis 184
CINRG pilot trial of coenzyme Q10 in steroid-treated Duchenne muscular dystrophy. 180
Oxidative stress modulation in neurodegenerative diseases 177
Astrocyte-neuron interactions in neurological disorders 173
Facioscapulohumeral muscular dystrophy type 1A in northwestern Tuscany: a molecular genetics-based epidemiological and genotype-phenotype study 171
Cardiac magnetic resonance imaging and management of dilated cardiomyopathy in a Duchenne muscular dystrophy manifesting carrier 169
Impaired oxidative metabolism in exercising muscle from ALS patients. 165
MPTP-induced Parkinsonism is associated with damage to Leydig cells and testosterone loss 164
Activation of brain metabolism and fos during limbic seizures: The role of Locus Coeruleus 162
Neurophysiological evaluation of vigilance in epileptic patients on monotherapy with lamotrigine 162
Alteration of lactate production during incremental excercise in myotonic dystrophy is not dependent by catecholamine increase 161
Lack of association between the APEX1 Asp148Glu polymorphism and sporadic Amyotrophic Lateral Sclerosis 161
Gly482Ser PGC-1α gene polymorphism and exercise-related oxidative stress in amyotrophic lateral sclerosis patients 161
The Italian multiple sclerosis register 161
Long-term follow-up of 106 multiple sclerosis patients undergoing IFN-ß 1a or 1b therapy: predictive factors of thyroid disease development and duration 159
The Role of Mitochondria in StemCell Biology 159
Relation between plasmatic and cerebrospinal fluid oxidative stress biomarkers and intrathecal ig synthesis in multiple sclerosis patients 158
Strategies for clinical approach to neurodegeneration in Amyotrophic lateral sclerosis. 158
The role of mitochondria in stem cell biology 158
Amyotrophic lateral sclerosis with long lasting disease course and SOD1 and TARDBP mutations: Report of two cases and overview of the literature. 157
Intracellular pathways underlying the effects of lithium 156
Does autophagy worsen or improve the survival of dopaminergic neurons? 154
Abnormal levels of human mitochondrial transcription factor A in skeletal muscle in mitochondrial encephalomyopathies. 154
CINRG randomized controlled trial of creatine and glutamine in Duchenne muscular dystrophy 152
Assessment of endogenous DNA oxidative stress in mitochondrial encephalomyopathies. 150
Lack of α1b-adrenergic receptor protects against epileptic seizures 150
Collaborative translational research leading to multicenter clinical trials in Duchenne muscular dystrophy: the Cooperative International Neuromuscular Research Group (CINRG) 148
H-MTTFA muscle levels in mitochondrial myopathies. 145
Clinical and demographic features of multiple sclerosis in an Italian register: a cross-sectional ecologic study 144
Sustained wakefulness combined with blood alcohol legal concentrations: effects on car driving performance. 143
Alpha-synuclein and autophagy as common steps in neurodegeneration 143
Metabolic muscle adaptation to aerobic training in patients affected by mitochondrial myopathies. 143
Predictive factors of thyroid disease during sustained INF-ß therapy in 106 multiple sclerosis patients 141
A case of comorbidity between multiple sclerosis and multiple system atrophy 140
Role of autophagy during methamphetamine neurotoxicity 139
Autophagy, lithium, and amyotrophic lateral sclerosis 136
Occurrence of IgG oligoclonal bands in upper motor neuron disease: just by chance? 135
Plasmatic oxidative stress biomarkers in multiple sclerosis: Relation with clinical and demographic characteristics. 135
DMTs and Covid-19 severity in MS: a pooled analysis from Italy and France 135
Subacute Alzheimer’s disease with prominent white matter involvement. Report of a pathologically-confirmed case 134
Spinal cord and parkinsonism: Neuromorphological evidences in humans and experimental studies. 133
Molecular diagnostics and mitochondrial dysfunction: a future perspective 133
MPTP- but not methamphetamine-induced parkinsonism extends to catecholamine neurons in the gut 131
Facio-scapulo-humeral muscular dystrophy in North-West Tuscany: A clinically and molecularly based epidemiological study 130
Metabolic and muscle adaptation to aerobic training in CPEO patients. 129
Gastric emptying in myotonic dystrophic patients. 129
Genetic or pharmacological blockade of noradrenaline synthesis enhances the neurochemical, behavioral, and neurotoxic effects of methamphetamine 129
Cell To Cell Spreading Of Misfolded Proteins As A Therapeutic Target In Motor Neuron Disease. 129
Advanced oxidation protein products in serum of patients with myotonic disease type I: association with serum gamma-glutamyltransferase and disease severity 128
Plasma redox and inflammatory patterns during major depressive episodes: A cross-sectional investigation in elderly patients with mood disorders 128
Motor neuron pathology and behavioral alterations at late stages in a SMA mouse model. 127
Methamphetamine Fails to Alter the Noradrenergic Integrity of the Heart A Comparison with the Parkinsonism-Inducing Neurotoxin MPTP 126
Limb girdle muscular dystrophy type 2a associated with epilepsy: a case report. 126
High number of striatal dopaminergic neurons during early postnatal development: correlation analysis with dopaminergic fibers 126
Do Thyroid autoimmunity and dysfunction predict clinical outcome of multiple sclerosis patients trated with IFN-β? 125
Very late onset multiple sclerosis likely associated with restless legs syndrome. A case report. 125
Effects of Alzheimer's disease and mild cognitive impairment on driving ability: a controlled clinical study by simulated driving test 125
Parkinson’s disease and the gut: a well known clinical association in need of an effective cure and explanation 124
Facio-scapulo-humeral dystrophy in north-west Tuscany: a molecular genetics-based epidemiological and genotype-phenotype study 123
Facio-scapulo-humeral dystrophy in north-west Tuscany: a molecular genetics-based epidemiological and genotype-phenotype study 122
Pathways of methamphetamine toxicity 122
Kennedy’s disease: a case report. 120
Lactate production and catecholamine profile during aerobic exercise in normotensive OSAS patients 120
Oxidative stress in myotonic dystrophy type 1 119
Plasmatic oxidative stress biomarkers in multiple sclerosis patients with different clinical course 119
Pharmacogenetics of myotonic hNav1.4 sodium channel variants situated near the fast inactivation gate. 119
Defining disease pathogenesis by comparative cross-species profiling in human and mouse knock-outs: the downstream consequences of dystrophin deficiency. 117
Review of the clinical evidence for interferon beta 1a (Rebif) in the treatment of multiple sclerosis 117
Frederich’s ataxia: a case report. 116
Profiling of Canonical and Non-Traditional Cytokine Levels in Interferon-β-Treated Relapsing-Remitting-Multiple Sclerosis Patients 116
Miopatie tossiche e da farmaci 115
H-MTTFA muscle levels in mitochondrial myopathies 115
Caso clinico: cardiopatia in una portatrice di distrofia muscolare di Duchenne 114
Malattie neurologiche in gravidanza 113
Magnetization Transfer Imaging Of Cortical Motor System In Als Patients At Early Stage of Disease 113
The importance of nasal resistance in obstructive sleep apnea syndrome: a study with positional rhinomanometry. 113
Sudden death in epilepsy: Two case reports 111
Cardiomiopatia dilatativa familiare associata a miopatia 111
The role of autophagy: what can be learned from the genetic forms of amyotrophic lateral sclerosis 111
Altered lactate kinetics from exercising muscle in Hereditary Spastic Paraplegia. 110
SARS-CoV-2 serology after COVID-19 in multiple sclerosis: An international cohort study 110
I farmaci inibitori delle colinesterasi nel trattamento dei disturbi psichici e comportamentali nella malattia di Azheimer: focus su galantamina 109
Defining disease pathogenesis by comparative cross-species profiling in human and mouse knock-outs: the downstream consequences of dystrophin deficiency. 108
Epidemiology of facio-scapulo-humeral dystrophy in north-west Tuscany: a molecular genetics-based revisitation. 107
Complicanze gastrointestinali in pazienti neurologici trattati con glucocorticoidi: terapia con gli inibitori di pompa protonica 107
Multiple Sclerosis and Neurofibromatosis type1: case report 107
Lithium therapy is able to reduce oxidative stress in amyotrophic lateral sclerosis patients 107
Diagnosi e terapia della malattia di Parkinson 105
Effetti psichici e comportamentali dei farmaci antiepilettici nell’adulto 105
Creatine and glutamine therapeutic trial in Duchenne muscular dystrophy (DMD) by the Cooperative International Neuromuscular Research Group (CINRG) 105
PLASMATIC AND CEREBROSPINAL FLUID OXIDATIVE STRESS BIOMARKERS IN ACUTE AND CHRONIC POLYRADICULONEUROPATHIES 104
Chronic inflammatory demyelinating polyradiculoneuropathy in children 103
Defining disease pathogenesis by comparative cross-species profiling in human and mouse knock-outs: the downstream consequences of dystrophin deficiency 103
Effects of lithium administration on oxidative stress markers in amyotrophic lateral sclerosis patients 101
Totale 13.970
Salva come PNG Salva come JPEG
Categoria #
all - tutte 45.188
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 45.188
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021874 81 25 76 73 85 28 84 85 66 66 57 148
2021/20221.460 23 107 27 69 284 203 51 108 78 46 92 372
2022/20232.026 198 248 138 194 228 271 33 146 336 18 192 24
2023/20241.570 184 155 250 112 205 281 61 29 31 54 77 131
2024/20254.935 73 205 41 259 511 444 738 224 444 582 497 917
2025/202673 73 0 0 0 0 0 0 0 0 0 0 0
Totale 17.217